Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2025-08-28
DOI
https://doi.org/10.3324/haematol.2025.287954
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study

Karim Belhadj Merzoug, Laurence Sanhès, Driss Chaoui, Hubert Orfeuvre et al.
Haematologica
Multiple Myeloma Research and Treatments
article

Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study

Karim Belhadj Merzoug, Laurence Sanhès, Driss Chaoui, Hubert Orfeuvre, Ronan Garlantézec, Jean Bastié, Murielle Roussel, Lionel Karlin, Caroline Jacquet, Cécile Sonntag, Arthur Bobin, Margaret Macro, M. Bouketouche, Laure Vincent, Thomas Chalopin, Bruno Royer, Aurore Perrot, Sophie Rigaudeau, Cyrille Hulin, Laurent Frenzel, Mohamad Mohty, Olivier Decaux, Jean Eudes Fontan
article en

Abstract

No abstract available for this paper.
HaematologicaVol. 111(2)
Délégation Paris 5 (FR), Hôpital Necker-Enfants Malades (FR), Inserm (FR), Centre Hospitalier Universitaire Henri-Mondor (FR), Sorbonne Université (FR), Centre Hospitalier Universitaire de Besançon (FR), Centre Hospitalier de Perpignan (FR), Centre Hospitalier de Saint-Quentin (FR), Centre Hospitalier Universitaire de Tours (FR), Institut universitaire du cancer de Toulouse Oncopole (FR), Centre Hospitalier Régional et Universitaire de Nancy (FR), Centre Hospitalier Universitaire de Poitiers (FR), Centre Hospitalier Universitaire de Caen Normandie (FR), CHU Dijon Bourgogne (FR), Hôpital Debrousse (FR), Hôpital André Mignot (FR), Hôpital Cardiologique du Haut-Lévêque (FR), Centre Hospitalier Victor Dupouy (FR), Hôpital Louis Pradel (FR), Hôpital Saint-Jacques (FR), Hôpital Saint Eloi (FR), Hôpital Saint-Louis (FR), Centre Hospitalier Universitaire de Rennes (FR), Hôpital d'Hautepierre (FR), Centre Hospitalier de Versailles (FR), Hôpital Dupuytren (FR)
Openalex Percentile: Top 71%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.